Skip to content
Log in
Sponsored AI Networking Cookbook: Practical recipes for AI-assisted network automation and development AI Networking Cookbook: Practical recipes for AI-assisted network automation and development

Author

Walid E. Elgammal

h-index 16 View on Semantic Scholar

We have 6 of 75 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Dual-action antibacterial and anticancer agents: Design, synthesis, and mechanistic investigation of novel 4H-pyran-pyrazole hybrids.

This study involved the design, synthesis, and comprehensive biological evaluation of a new library of 4H-pyran-pyrazole hybrid molecules. The compounds were synthesized via versatile multicomponent and cyclocondensation reactions and characterized using spectroscopic techniques. Their biological potential was assessed...

Salwa Aljohani, S. Zaki, Asma Obaidallah Alatawi et al. · 0 citations
Sep 2026

Integrated in vitro and in silico evaluations of novel benzanilide derivatives as anticancer agents.

AIMS This study aimed to design, synthesize, and evaluate novel benzanilide derivatives as potential anticancer agents targeting VEGFR-2-mediated tumor angiogenesis. MATERIALS AND METHODS Eight benzanilide derivatives (7a-e, 9a-b, and 11) were synthesized and structurally confirmed using spectroscopic methods. The co...

A. Metwaly, Hazem Elkady, Walid E. Elgammal et al. · 0 citations
Open access Aug 2026

Coumarin-based dual kinase inhibitors targeting CDK6 and VEGFR-2: experimental and computational validation

Mechanistic studies revealed that compound 7e induced significant apoptosis, promoted S-phase cell cycle arrest, and effectively inhibited cell migration in HCT-116 cells, identifying him as a promising dual VEGFR-2/CDK6 inhibitor with potent and selective anticancer activity.

Hazem Elkady, Walid E. Elgammal, I. Eissa et al. · 0 citations
Aug 2026

Integrated In Silico and In Vitro Discovery of a VEGFR-2-Targeted Anticancer Benzanilide Lead

This integrated study pinpointed ACEB-Cl as a promising VEGFR-2targeted anticancer lead compound with strong inhibitory potency, and a clearly defined mechanism of action, supporting its progression for further improvement.

A. Metwaly, I. Eissa, Walid E. Elgammal et al. · 0 citations
Open access Aug 2026

Integrated design, synthesis, biological evaluation, and computational mechanistic insights of novel benzanilide derivatives as VEGFR-2 targeted anticancer agents

Findings identify compound 7e as a promising VEGFR-2-targeted anticancer lead with strong enzymatic inhibition, potent cytotoxicity, and a well-supported mechanistic profile integrating experimental and computational evidence.

A. Metwaly, Walid E. Elgammal, I. Eissa et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.